Dr. Zahra Dantes

Evaluator
DISC Type : Csd

Chief Scientific Officer (CSO), Europe, Asia, Brazil at Invitrocue Europe AG

Munich, Bavaria, Germany

Overview

Dr. Zahra Dantes is the Chief Scientific Officer at Invitrocue, with over 15 years of experience in translational oncology research. Holding a Ph. D. from the Technical University of Munich, she leads global medical strategy and is described by colleagues as having exceptional communication skills and deep knowledge of cancer biology.

Outside of her scientific work, she is a passionate advocate for human rights, using her platform to raise awareness for social issues in her home country of Iran. She also follows developments in broader health topics, such as the link between nutrition and cancer.

She possesses a unique dual expertise as both a Ph. D. in Molecular Medicine and a qualified Veterinary Pathologist.

Personality Overview

Hard To Convince

Thorough Evaluator

Fast But Analytical

They have a unique set of diverse traits where they are decisive and methodical but can sometimes be extra cautious and skeptical  They are not very likely to become strong advocates of your product or service They focus on the results, but can still be quite procedural and analytical about how to get there

Topics They Care About

Personalized Oncology
Her career is dedicated to using Patient-Derived Organoids (PDOs) as precision medicine platforms to find the most effective therapies for cancer patients.
Translational Research
She is passionate about bridging the gap between early research and clinical implementation to ensure scientific discoveries directly benefit patients.
Patient-Derived Organoids
With over 12 years of experience in PDOs, she has established labs and led numerous validation studies on this technology for solid cancers.

Media Appearances

Our Team - Dr. Zahra Dantes, Chief Scientific Officer (CSO), Europe, Asia, Brazil. Featured in Invitrocue

See Now

Publications featuring Dr. Zahra Dantes. Featured in Invitrocue

See Now

Work History

10-2019
Chief Scientific Officer (CSO), Europe, Asia, Brazil at Invitrocue Europe AG
5-2019 - 1-2021
Postdoctoral Fellow at Klinikum rechts der Isar
5-2019 - 9-2019
Scientist at Invitrocue
9-2014 - 4-2019
PHD at Klinikum rechts der Isar

Education

9-2014 - 4-2019
Doctor of Philosophy - PhD from Technical University of Munich
9-2023 - 9-2023
Executive Education from INSEAD

More Information

Social Presence :

Prographics :

Exp : 11 Location : Munich, Bavaria, Germany Job Level : Leadership Designation : Chief Scientific Officer (CSO), Europe, Asia, Brazil at Invitrocue Europe AG
URL has been copied!

Insights For Selling To Dr. Zahra

During A Call Or A Meeting

DO's

  • Keep a professional, business-like approach; especially if you tend to get informal quickly
  • Help them see both - the ‘big picture’ impact and the ROI of the investment
  • Use phrases like ‘the ROI of this’, ‘X% more’ etc.

DONT's

  • Don’t focus on relationship, focus purely on the merit of your product
  • Avoid self-deprecating references or general informality, it could decrease their trust in you
  • Avoid too much small talk, just a few formal pleasantries should be fine

When Cold Calling

When Writing An Email

While Negotiating & Closing

    The secret to closing fast with Dr. Zahra is

  • ROI matters the most to them, followed by process and finally proof of results
  • Will you ever get a clear answer from Dr. Zahra

  • They might hesitate a little, but will go ahead and say no when necessary (or asked)

Insights For Deal Planning

    How fast (or slow) will Dr. Zahra move?

  • They are unlikely to move very fast, especially when it comes to new products or services
  • Can Dr. Zahra take some risk or not?

  • They have relatively low risk-appetite and are not very likely to go for something unproven and risky

You And Dr. Zahra

Personality Compatibility


More Profiles

Discover additional public profiles from our index.

Search more profiles

Looking for someone else? Search here for anyone.

Or visit Humantic AI to know more.